Comment je traite ... Place de la metformine en gynecologie-obstetrique.

Breast Neoplasms/drug therapy; Diabetes, Gestational; Endometrial Neoplasms/drug therapy; Female; Humans; Hypoglycemic Agents/therapeutic use; Metformin/therapeutic use; Polycystic Ovary Syndrome; Pregnancy; Endometrial cancer; Gestational diabetes; Metformin; Breast cancer

Abstract :

[en] Metformin raises much interest in the fields of gynaecology and obstetrics. This article discusses both the efficacy and safety of metformin in the management of polycystic ovary syndrome as well as in the prevention, treatment and follow-up of gestational diabetes. Recent observational data suggest that metformin may also exert positive effects as adjuvant therapy in some cancers, among which endometrial cancer and breast cancer.

Disciplines :

Endocrinology, metabolism & nutrition
Reproductive medicine (gynecology, andrology, obstetrics)
Pharmacy, pharmacology & toxicology

Author, co-author :

Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques

Philips, Jean-Christophe ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques

Kridelka, Frédéric ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie-Obstétrique

Language :

French

Title :

Comment je traite ... Place de la metformine en gynecologie-obstetrique.

Alternative titles :

[en] Role of metformin in gynaecology and obstetrics

Publication date :

2018

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

597-602

Peer reviewed :

Peer reviewed

Available on ORBi :

since 10 June 2019

Statistics

Number of views

144 (4 by ULiège)

Number of downloads

71 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Scheen AJ, Lefèbvre PJ, Paquot N. La metfformine revisitée: moins de restrictions et davantage d'indications. Rev Med Liege, 2018, 11, 544-549.
Romero R, Erez O, Huttemann M, et al. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol, 2017, 217, 282-302.
Sivalingam VN, Myers J, Nicholas S, et al. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Hum Reprod Update, 2014, 20, 853-868.
Sinai Talaulikar V, Tang T, Yasmin E. Role of metformin in women's health: review of its current place in clinical practice and emerging indications for future. Obstet Gynecol Surv, 2016, 71, 307-317.
Mathur R, Alexander CJ, Yano J, et al. Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol, 2008, 199, 596-609.
Naderpoor N, Shorakae S, de Courten B, et al. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update, 2015, 21, 560-574.
Xu Y, Wu Y, Huang Q. Comparison of the effect between pioglitazone and metformin in treating patients with PCOS: a meta-analysis. Arch Gynecol Obstet, 2017, 296, 661-677.
Sam S, Ehrmann DA Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome. Diabetologia, 2017, 60, 1656-1661.
Practice Committee of the American Society for Reproductive Medicine. Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline. Fertil Steril, 2017, 108, 426-441.
Haas J, Bentov Y. Should metformin be included in fertility treatment of PCOS patients? Med Hypotheses, 2017, 100, 54-58.
Tan X, Li S, Chang Y, et al. Effect of metformin treatment during pregnancy on women with PCOS: a systematic review and meta-analysis. Clin Invest Med, 2016, 39, E120-131.
Zeng XL, Zhang YF, Tian Q, et al. Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Medicine (Baltimore), 2016, 95, e4526.
Zhao J, Liu X, Zhang W. The effect of metformin therapy for preventing gestational diabetes mellitus in women with polycystic ovary syndrome: a meta-analysis. Exp Clin Endocrinol Diabetes, 2018, Jun 11. doi:10.1055/a-0603-3394. [Epub ahead of print].
Chiswick C, Reynolds RM, Denison F, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol, 2015, 3, 778-786.
Syngelaki A, Nicolaides KH, Balani J, et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med, 2016, 374, 434-443.
Simmons D. Prevention of gestational diabetes mellitus: Where are we now? Diabetes Obes Metab, 2015, 17, 824-834.
Agha-Jaffar R, Oliver N, Johnston D, et al. Gestational diabetes mellitus: does an effective prevention strategy exist? Nat Rev Endocrinol, 2016, 12, 533-546.
Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med, 2008, 358, 2003-2015.
Nachum Z, Zafran N, Salim R, et al. Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study. Diabetes Care, 2017, 40, 332-337.
Li G, Zhao S, Cui S, et al. Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs. Arch Gynecol Obstet, 2015, 292, 111-120.
Brown J, Martis R, Hughes B, et al. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database Syst Rev, 2017, 1, CD011967.
Langer O. Pharmacological treatment of gestational diabetes mellitus: point/counterpoint. Am J Obstet Gynecol, 2018, 218, 490-499.
Liang HL, Ma SJ, Xiao YN, et al. Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis. Medicine (Baltimore), 2017, 96, e7939.
Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care, 2007, 30 Suppl 2, S251-260.
Kalafat E, Sukur YE, Abdi A, et al. Metformin for the prevention of hypertensive disorders of pregnancy in women with gestational diabetes and obesity: a systematic review and meta-analysis. Ultrasound Obstet Gynecol, 2018, 52, 706-714.
Society of Maternal-Fetal Medicine Publications Committee. SMFM Statement: Pharmacological treatment of gestational diabetes. Am J Obstet Gynecol, 2018, 218, B2-B4.
Barbour LA, Scifres C, Valent AM, et al. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol, 2018, 219, 367.
National Institute of Health and Care Excellence. - Gestational diabetes: risk assessment, testing, diagnosis and management. https://pathways.nice.org.uk/pathways/diabetes-in-pregnancy, 2018 (latest access September 15, 2018).
Gray SG, McGuire TM, Cohen N, et al. The emerging role of metformin in gestational diabetes mellitus. Diabetes Obes Metab, 2017, 19, 765-772.
Tieu J, Shepherd E, Middleton P, et al. Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes. Cochrane Database Syst Rev, 2017, 8, CD010211.
Ratner RE, Christophi CA, Metzger BE, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab, 2008, 93, 4774-4779.
Kasher-Meron M, Grajower MM Preventing progression from gestational diabetes mellitus to diabetes: A thought-filled review. Diabetes Metab Res Rev, 2017, 33. doi:10.1002/dmrr.2909. Epub 2017 Jun 16.
Beck E, Scheen AJ La metformine: une molécule antidiabétique dotée de propriétés anti-cancéreuses. Rev Med Liege, 2013, 68, 444-449.
Gadducci A, Biglia N, Tana R, et al. Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning. Crit Rev Oncol Hematol, 2016, 105, 73-83.
Clement NS, Oliver TR, Shiwani H, et al. Metformin for endometrial hyperplasia. Cochrane Database Syst Rev, 2017, 10, CD012214.
Meireles CG, Pereira SA, Valadares LP, et al. Effects of metformin on endometrial cancer: Systematic review and meta-analysis. Gynecol Oncol, 2017, 147, 167-180.
Chu D, Wu J, Wang K, et al. Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis. BMC Cancer, 2018, 18, 438.
Perez-Lopez FR, Pasupuleti V, Gianuzzi X, et al. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus. Maturitas, 2017, 101, 6-11.
Xie W, Li T, Yang J, et al. Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis. Oncotarget, 2017, 8, 73079-73086.
Col NF, Ochs L, Springmann V, et al. Metformin and breast cancer risk: a meta-analysis and critical literature review. Breast Cancer Res Treat, 2012, 135, 639-646.
Yang T, Yang Y, Liu S. Association between metformin therapy and breast cancer incidence and mortality: evidence from a meta-analysis. J Breast Cancer, 2015, 18, 264-270.
Xu H, Chen K, Jia X, et al. Metformin Use is associated with better survival of breast cancer patients with diabetes: a meta-analysis. Oncologist, 2015, 20, 1236-1244.
Tang GH, Satkunam M, Pond GR, et al. Association of metformin with breast cancer incidence and mortality in patients with type II diabetes: A GRADE-assessed systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev, 2018, 27, 627-635.